US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011

Featured Stories

Courts Rule On DOJ Trans Care Subpoena, Abortion And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at a split Ninth Circuit decision backing the U.S. Department of Justice's administrative subpoena o... (more story)

Iowa Board Opens Door For Doctor Self-Defense Arguments No Photo Available

Mark Payne

An Iowa medical board's decision to dismiss disciplinary charges against a doctor who claimed the state's "stand your ground" law enab... (more story)

Lilly's Obesity Drug Suits Signal New Reality For GLP-1 Giants No Photo Available

Yeji Jesse Lee

Obesity-drug makers haven’t been shy about suing players encroaching on their turf. But a new round of lawsuits from Eli Lilly may sig... (more story)